181 results on '"Jux, Christian"'
Search Results
2. Cardiomyocyte maturation alters molecular stress response capacities and determines cell survival upon mitochondrial dysfunction
3. Cardiomyocyte hyperplasia and immaturity but not hypertrophy are characteristic features of patients with RASopathies
4. Edoxaban for Thromboembolism Prevention in Pediatric Patients With Cardiac Disease
5. Histopathology of congestive nephropathy: a case description and literature review.
6. Reversible, schwere Kardiomyopathie als Folge einer langsamen, permanenten Schmalkomplextachykardie
7. Natural history of pulmonary atresia with intact ventricular septum (PAIVS) and critical pulmonary stenosis (CPS) and prediction of outcome
8. The p.Ala2430Val mutation in filamin C causes a "hypertrophic myofibrillar cardiomyopathy"
9. Long-term outcome of perimembranous VSD closure using the Nit-Occlud® Lê VSD coil system
10. Associated Anomalies and Outcome in Patients with Prenatal Diagnosis of Aortic Arch Anomalies as Aberrant Right Subclavian Artery, Right Aortic Arch and Double Aortic Arch.
11. Neonatal myocardial infarction: substantial improvement of cardiac function after autologous bone marrow-derived cell therapy
12. Somatic Development in Children with Congenital Heart Defects
13. Genetic basis of hypertrophic cardiomyopathy in children
14. Reduced Biventricular Volumes and Myocardial Dysfunction Long-term After Pediatric Heart Transplantation Assessed by CMR
15. Advances in heart failure therapy in pediatric patients with dilated cardiomyopathy
16. Dietary protein restriction throughout intrauterine and postnatal life results in potentially beneficial myocardial tissue remodeling in the adult mouse heart
17. Creation of a functional Potts shunt by stenting the persistent arterial duct in newborns and infants with suprasystemic pulmonary hypertension of various etiologies
18. Letter by Rupp and Jux Regarding Article, “Mechanisms of Cardiac Repair and Regeneration”
19. Left Ventricular Physiology and Ventricular-Vascular Interactions in Young Patients After Heart Transplantation.
20. Pulmonary artery banding in infants and young children with left ventricular dilated cardiomyopathy: A novel therapeutic strategy before heart transplantation
21. Genetic Screening Reveals Heterogeneous Clinical Phenotypes in Patients with Dilated Cardiomyopathy and Troponin T2 Variants.
22. Fifteen-year Single Center Experience with the “Giessen Hybrid” Approach for Hypoplastic Left Heart and Variants: Current Strategies and Outcomes
23. Somatic Development in Children with Congenital Heart Defects
24. Fetal Echocardiography in Predicting Postnatal Outcome in Borderline Left Ventricle.
25. Exercise-dependent changes in ventricular–arterial coupling and aortopulmonary collateral flow in Fontan patients: a real-time CMR study.
26. Stenting of Native Right Ventricular Outflow Tract Obstructions in Symptomatic Infants
27. Beneficial Effects of Residual Right Ventricular Outflow Tract Obstruction on Right Ventricular Volume and Function in Patients After Repair of Tetralogy of Fallot
28. Arrhythmogene rechtsventrikuläre Dysplasie/Cardiomyopathie: Diagnostik im Kindesalter
29. Novel Catheter-Interventional Strategy for Intracardiac Connecting of Total Anomalous Pulmonary Venous Return in Newborns With Hypoplastic Left Heart-Syndrome Prior to Hybrid Approach
30. Two Melodies in Concert: Transcatheter Double-Valve Replacement
31. Interventional Atrial Septal Defect Closure Using a Totally Bioresorbable Occluder Matrix: Development and Preclinical Evaluation of the BioSTAR Device
32. Fate of a Modified Fenestration of Atrial Septal Occluder Device after Transcatheter Closure of Atrial Septal Defects in Elderly Patients
33. Stent Implantation of the Arterial Duct in Newborns with a Truly Duct-Dependent Pulmonary Circulation: A Single-Center Experience with Emphasis on Aspects of the Interventional Technique
34. BioSTAR® bioabsorbable septal repair implant
35. Biocompatibility of septal defect closure devices
36. Transcatheter Closure of Perimembranous Ventricular Septal Defects Using Umbrella Devices
37. Retrograde use of the Cardioseal/Starflex occluder device
38. Single Nuclei Sequencing Reveals Novel Insights Into the Regulation of Cellular Signatures in Children With Dilated Cardiomyopathy.
39. Symptom-orientated oral hygiene for children after heart transplantation: Effectiveness of a standardized prophylactic program.
40. Histopathological Workup of an Amplatzer Atrial Septal Defect Occluder After Surgical Removal
41. Interrelationship Between Hemodynamics, Brain Volumes, and Outcome in Hypoplastic Left Heart Syndrome.
42. Fibrotic myocardial remodeling in children and adolescents after cardiac transplantation - a CMR native T1 mapping study.
43. Prenatal Mechanistic Target of Rapamycin Complex 1 (m TORC1) Inhibition by Rapamycin Treatment of Pregnant Mice Causes Intrauterine Growth Restriction and Alters Postnatal Cardiac Growth, Morphology, and Function.
44. Hypoplastic Left Heart Syndrome (HLHS).
45. Cardiovascular magnetic resonance assessment of ventricular function and myocardial scarring before and early after repair of anomalous left coronary artery from the pulmonary artery.
46. Dexamethasone impairs growth hormone (GH)-stimulated growth, by supporession of local insulin-like growth factor (IGF)-I production and expression of GH- and IGC-1 receptor in cultured rat chondrocytes
47. Intracoronary bone marrow cell application for terminal heart failure in children.
48. Large-diameter graft-stent (Advanta V12) implantation in various locations: early results.
49. Piccolo devices in premie ductus arteriosi.
50. BioSTAR Evaluation STudy (BEST): a prospective, multicenter, phase I clinical trial to evaluate the feasibility, efficacy, and safety of the BioSTAR bioabsorbable septal repair implant for the closure of atrial-level shunts.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.